Developing new contraceptive methods for women, especially those who are obese.
Official title: CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM – CORE FUNCTION ACTIVITIES FOR SITES OF FEMALE CONTRACEPTIVE STUDIES - UC DAVIS
Funded at University of California at Davis · NIH-11127344 · Data updated 2026-11-12
This study is looking for women, especially those who are obese, to help test new birth control options that aim to prevent unintended pregnancies while keeping safety in mind, so you can have choices that work better for your health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $20,410 |
| NIH project number | 75N94020D00002-P00004-759402000001-1 |
| Project ID | NIH-11127344 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include women seeking effective contraception, especially those who are obese or have medical conditions that make current contraceptive options unsuitable.
✕Less likely to help
Patients who are not seeking contraception or who do not have any health conditions that affect contraceptive use may not benefit from this research.
What this research studies
This research focuses on creating new contraceptive options that effectively prevent unintended pregnancies while also minimizing the risk of venous thromboembolism (VTE), particularly in obese women. The Contraceptive Clinical Trials Network (CCTN) will develop and implement clinical trial protocols aimed at testing these new contraceptive methods. By involving women with various health conditions, the research seeks to ensure that the new contraceptives are safe and effective for a broader population. Participants may have the opportunity to contribute to the development of contraceptives that better meet their needs.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective contraceptive options for women, particularly those at higher risk due to obesity.
How similar studies have gone: Previous research in contraceptive development has shown promise in creating safer options, indicating that this approach has potential for success.
Where this research is happening
-
University of California at Davis
Davis, United States Active
Researchers
- Principal investigator: Creinin, Mitchell — University of California at Davis
- Study coordinator: Creinin, Mitchell
Related research
Other NIH-funded projects on the same topics.
-
An integrated mobile health program to reduce SAVA and mental health problems among female sex workers in Kenya
A new mobile health program aims to help female sex workers in Kenya avoid substance abuse, violence, HIV, and depression by delivering group therapy, online resources, and a peer discussion space.
-
HIV in Women: How the virus hides and the immune system changes across life stages
This project looks at how HIV behaves differently in people from puberty through menopause, focusing on how hormones like estrogen may affect HIV persistence and immune responses.
-
Mobile health support to boost PrEP and contraception use among young women in Zambia
A mobile health program helps female university students in Zambia learn about and access HIV prevention and contraception.
-
Computational modeling of female hormone balance and drug responses
A new computational model uses patient-like data to predict how metabolic drugs will work in women across their hormonal cycles and different reproductive stages.
-
How PrEP Drugs Affect HIV Risk in Women and Reproductive Health
This project looks at how PrEP medicines work for women, and whether they influence pregnancy-related processes in the uterus.
-
How female eggs throw away most chromosomes during meiosis
A scientist at UC Davis is studying why only a quarter of chromosomes go into the egg during female reproductive cell division and how errors in this process can cause miscarriage or birth defects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.